Allergy/Imm Medical News about Human Papilloma Virus

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cost-Effectiveness Analysis of a Quadrivalent Human Papilloma Virus Vaccine in Mexico
Archives of Medical Research, 11/05/09

Reynales–Shigematsu LM et al. – The results of this study could be of great value in decision–making for the implementation of an HPV vaccine as a public health policy in Mexico provided that the cost of each dose will be, at most, $15 dollars (USD) dollars, combined with HPV testing, the new strategy of national secondary prevention program.

<< Previous
Agent-based simulation of T-cell activation and proliferation...

Next >>
Trends in Multidrug Treatment Failure and Subsequent Mortality...

Human papilloma virus in head and neck cancer: The need for a standardised assay to assess the full clinical importance
European Journal of Cancer, 10/01/09 Relevance Score: 80%

Ethical Dilemmas and Great Expectations for Human Papilloma Virus Vaccination
Archives of Medical Research, 10/26/09 Relevance Score: 79%

Precancerous anal lesions may be very common in some populations: protease inhibitor therapy may help
AIDSmap, 11/17/09 Relevance Score: 78%

Multicenter Study of Knowledge About Human Papilloma Virus and Attitudes Among Emergency Department Patients
Journal of Pediatric and Adolescent Gynecology, 11/04/09 Relevance Score: 78%

High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer
Breast Cancer Research and Treatment, 10/28/09 Relevance Score: 78%